Chemical Component Summary

NameD-ERITADENINE
Identifiers(2R,3R)-4-(6-aminopurin-9-yl)-2,3-dihydroxy-butanoic acid
FormulaC9 H11 N5 O4
Molecular Weight253.22
TypeNON-POLYMER
Isomeric SMILESNc1ncnc2n(C[C@@H](O)[C@@H](O)C(O)=O)cnc12
InChIInChI=1S/C9H11N5O4/c10-7-5-8(12-2-11-7)14(3-13-5)1-4(15)6(16)9(17)18/h2-4,6,15-16H,1H2,(H,17,18)(H2,10,11,12)/t4-,6-/m1/s1
InChIKeyLIEMBEWXEZJEEZ-INEUFUBQSA-N

Chemical Details

Formal Charge0
Atom Count29
Chiral Atom Count2
Chiral AtomsC2', C3'
Bond Count30
Aromatic Bond Count10
Leaving Atomsn/a

Drug Info: DrugBank

DrugBank IDDB03769 Different stereochemistry
NameD-Eritadenine
Groupsexperimental
Synonyms
  • Eritadenine
  • Lentinacin
  • Lentysine
Categories
  • Heterocyclic Compounds
  • Heterocyclic Compounds, 2-Ring
  • Purines
CAS number23918-98-1

Drug Targets

NameSequence SearchPharmacological ActionActions
AdenosylhomocysteinaseMSDKLPYKVADIGLAAWGRKALDIAENEMPGLMRMRERYSASKPLKGARI...unknown
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682